Beating Cancer: How Cutting Sugar Reversed One Man s Death Sentence cbn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cbn.com Daily Mail and Mail on Sunday newspapers.
(0)
Novocure (NASDAQ: NVCR) today announced that the U.S. Food and Drug Administration (FDA) has approved its investigational device exemption (IDE) application to initiate the KEYNOTE-B36 trial, conducted in collaboration with MSD (Merck Co., Inc., Kenilworth, NJ, USA). Novocure also announced the members of its scientific steering committee who will provide expert opinions and recommendations regarding enrollment strategies, country distribution, study timelines and other scientific topics. The KEYNOTE-B36 trial will evaluate Tumor Treating Fields (TTFields) together with pembrolizumab for first-line treatment of locally advanced or metastatic intrathoracic, PD-L1 positive non-small cell lung cancer (NSCLC).
KEYNOTE-B36 steering committee members include:
Corey Langer, M.D., director of thoracic oncology and professor of medicine at the Hospital of the University of Pennsylvania
(Photo by Alexandru Pavalache\EyeEm\Getty Images)
The Cleveland Clinic and Mayo Clinic are leading a coalition of 60 hospitals and healthcare institutions in a nationwide campaign to encourage adults to get vaccinated against COVID-19.
Get the Vaccine to Save Lives is designed to reassure the public that vaccines are safe, effective and necessary to achieve herd immunity and return to normal, according to the Cleveland Clinic. The COVID-19 vaccine is safe and highly effective and offers our best hope for beating the disease, said Dr. Tom Mihaljevic, Cleveland Clinic s CEO and president.
Mayo Clinic s President and CEO Dr. Gianrico Farrugia said, The vaccine is our strongest asset to end the pandemic, and I urge everyone who is eligible to get whichever vaccine you re first offered to save lives.
AACC Honors 2021 Award Winners for Advancing Laboratory Medicine and Patient Care
News provided by
Share this article
Share this article
WASHINGTON, April 22, 2021 /PRNewswire/ AACC, a global scientific and medical professional organization dedicated to better health through laboratory medicine, is pleased to announce the recipients of the 2021 AACC and AACC Academy Awards. Through this annual awards program, AACC strives to support laboratory medicine professionals in all stages of their careers and to build awareness of the essential role that clinical laboratory testing plays in improving patient health.
2021 AACC Award Winners
Huestis & Smith Toxicology, LLC
University of Utah Health
CTI-Clinical Trial Services, Inc.
Arterial Thromboembolism Risk Varies Across Cancer Types, Ages medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.